RecruitingNot ApplicableNCT05835817

Magnetoencephalography by Optical Pumping Magnetometer


Sponsor

Centre Hospitalier Universitaire, Amiens

Enrollment

70 participants

Start Date

Apr 11, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

MagnetoEncephaloGraphy (MEG) is a method of recording brain activity with high temporal resolution and good spatial resolution, compared to current recording techniques such as ElectroEncephaloGraphy (EEG). The main limitation of MEG is its cost due to the sensors used, the Super Quantum Interference Devices (SQUID). These require a complex infrastructure from an instrumentation point of view to operate, requiring liquid helium, most often at a loss, at increasing cost. Optical Pumping Magnetometers (OPM) type sensors represent a promising alternative to SQUIDs sensors, especially since they do not require helium cooling. The purpose of this project is to Identify biomarkers in Magnetoencephalography of normal brain development in healthy adults, premature and term newborns from "a priori" obtained by the classical technique of High Resolution EEG performed.


Eligibility

Min Age: 1 Day

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Magnetoencephalography for people with magnetoencephalography, optical pump magnetometer, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMagnetoencephalography

40 minutes of Magnetoencephalography with Optical Pump Magnetometer


Locations(1)

CHU Amiens

Amiens, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05835817


Related Trials